Catherine Schulte
Stock Analyst at Baird
(4.28)
# 397
Out of 5,053 analysts
141
Total ratings
60.17%
Success rate
12.12%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $66.58 | +32.17% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $11.50 | +47.83% | 14 | Oct 24, 2025 | |
| A Agilent Technologies | Maintains: Outperform | $141 → $142 | $146.36 | -2.98% | 17 | Aug 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,432.57 | -14.14% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $576.35 | -1.62% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $211.17 | +8.44% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.10 | -35.48% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $43.17 | -0.39% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $57.46 | +18.34% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $34.74 | +9.38% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $30.96 | +6.59% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $121.72 | +130.86% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $376.57 | -42.37% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $206.63 | -90.32% | 1 | Jun 28, 2018 |
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $66.58
Upside: +32.17%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $11.50
Upside: +47.83%
Agilent Technologies
Aug 28, 2025
Maintains: Outperform
Price Target: $141 → $142
Current: $146.36
Upside: -2.98%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,432.57
Upside: -14.14%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $576.35
Upside: -1.62%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $211.17
Upside: +8.44%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.10
Upside: -35.48%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $43.17
Upside: -0.39%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $57.46
Upside: +18.34%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $34.74
Upside: +9.38%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $30.96
Upside: +6.59%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $121.72
Upside: +130.86%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $376.57
Upside: -42.37%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $206.63
Upside: -90.32%